Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mullin

Showing results (171-180 of 219) with videos related to

Pageof 22
Sort By:
British Journal of Cancer|August 26, 2004
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour modelsI K Dev, R E Dornsife, T M Hopper, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
The Liver is an Inflammatory Mediator of Pulmonary Arterial HypertensionNavneet Singh, Jordan Lawson, Ashok Ragavendran, et al.
Molecular Cancer Therapeutics|July 11, 2007
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activityRakesh Kumar, Victoria B Knick, Sharon K Rudolph, et al.
Journal of Neurodevelopmental Disorders|March 21, 2024
Differential cognitive and behavioral development from 6 to 24 months in autism and fragile X syndromeLindsay J Mullin, Joshua Rutsohn, Julia L Gross, et al.
Molecular Autism|May 15, 2026
Subclinical neuropsychiatric trait variation in parents of children with autism spectrum disorder: a cohort studyLindsay J Mullin, Kai Xia, Jeffrey Wang, et al.
Comprehensive Physiology|May 15, 2026
Exploring the Lung-Liver Axis in Pulmonary Arterial HypertensionNavneet Singh, Jordan Lawson, Ashok Ragavendran, et al.
Pulmonary Circulation|October 4, 2021
Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurementsTakahiro Sato, Bharath Ambale-Venkatesh, Stefan L Zimmerman, et al.
The European Respiratory Journal|June 30, 2018
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertensionGrayson L Baird, Christine Archer-Chicko, R Graham Barr, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsKirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Pageof 22

Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|August 26, 2004
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour modelsI K Dev, R E Dornsife, T M Hopper, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
The Liver is an Inflammatory Mediator of Pulmonary Arterial HypertensionNavneet Singh, Jordan Lawson, Ashok Ragavendran, et al.
Molecular Cancer Therapeutics|July 11, 2007
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activityRakesh Kumar, Victoria B Knick, Sharon K Rudolph, et al.
Journal of Neurodevelopmental Disorders|March 21, 2024
Differential cognitive and behavioral development from 6 to 24 months in autism and fragile X syndromeLindsay J Mullin, Joshua Rutsohn, Julia L Gross, et al.
Molecular Autism|May 15, 2026
Subclinical neuropsychiatric trait variation in parents of children with autism spectrum disorder: a cohort studyLindsay J Mullin, Kai Xia, Jeffrey Wang, et al.
Comprehensive Physiology|May 15, 2026
Exploring the Lung-Liver Axis in Pulmonary Arterial HypertensionNavneet Singh, Jordan Lawson, Ashok Ragavendran, et al.
Pulmonary Circulation|October 4, 2021
Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurementsTakahiro Sato, Bharath Ambale-Venkatesh, Stefan L Zimmerman, et al.
The European Respiratory Journal|June 30, 2018
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertensionGrayson L Baird, Christine Archer-Chicko, R Graham Barr, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsKirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Pageof 22